Triamcinolone

Thông số

124-94-7Số CAS

204-718-7Số EC

(8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-oneTên IUPAC

C21H27FO6Công thức hóa học

394.4 g/molKhối lượng phân tử

triamcinolone; 124-94-7; Fluoxyprednisolone; Kenacort; Rodinolone; Volon; Triamcinolon; Delphicort; Ledercort; Tricortale; Celeste; Omcilon; Triamcinolona; Triamcinolonum; Fluoxiprednisolone; Tiamcinolonum; CL 19823; 9alpha-Fluoro-16alpha-hydroxyprednisolone; 9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione; (8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one; DTXSID1040742; 1ZK20VI6TY; NSC-13397; NSC13397; CHEBI:9667; DTXCID9020742; 11beta,16alpha,17alpha,21-Tetrahydroxy-9alpha-fluoro-1,4-pregnadiene-3,20-dione; 9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione; Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,16alpha,17,21-tetrahydroxy-; Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11beta,16alpha); 9alpha-Fluoro-11beta,16alpha,17alpha,21-tetrahydroxypregna-1,4-diene-3,20-dione; Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11beta,16alpha)-; (11beta,16alpha)-9-Fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione; (1R,2S,10S,11S,13R,14S,15S,17S)-1-fluoro-13,14,17-trihydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo(8.7.0.0^(2,7).0^(11,15))heptadeca-3,6-dien-5-one; (1R,2S,10S,11S,13R,14S,15S,17S)-1-fluoro-13,14,17-trihydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-5-one; (8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta(a)phenanthren-3-one; RefChem:56151; (1R,2S,10S,11S,13R,14S,15S,17S)-1-fluoro-13,14,17-trihydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo(8.7.0.02,7.011,15)heptadeca-3,6-dien-5-one; 204-718-7; Aristocort; Triamcet; Triam-Tablinen; Cinolone-T; SK-Triamcinolone; Triamcinlon; Triamcinolonum [INN]; Triamcinalone; Tiamcinolonum [INN-Latin]; Triamcinolona [INN-Spanish]; Kenacort-AG; (8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one; C21H27FO6; Triamcinolone (Standard); Aristocort Tablets; MLS000028542; MLS001066543; 9.alpha.-Fluoro-16.alpha.-hydroxyprednisolone; MFCD00010477; SMR000058333; Prednisolone, 9-fluoro-16.alpha.-hydroxy-; NSC 13397; 51855-44-8; Kenacort (TN); Triamcinolone (Aristocort); 9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione; HSDB 3194; 9-alpha-Fluoro-16-alpha-hydroxyprednisolone; EINECS 204-718-7; UNII-1ZK20VI6TY; BRN 2341955; Prednisolone, 9-fluoro-16alpha-hydroxy-; 9-Fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione; 124-94-7 (free); Triamcinolone Acetonide Imp. A (EP); Triamcinolone; Triamcinolone Acetonide Impurity A; Triamcinolone CRS; 9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione; 9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione; Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11.beta.,16.alpha.)-; NCGC00094799-01; CAS-124-94-7; Triamcinolone [USP:INN:BAN:JAN]; Prestwick_438; 9-alpha-Fluoro-11-beta,16-alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione; 11-beta,16-alpha,17-alpha,21-Tetrahydroxy-9-alpha-fluoro-1,4-pregnadiene-3,20-dione; Triamcinolone Acetonide EP Impurity A; Triamcinolone, topical; Prestwick0_000120; Prestwick1_000120; Prestwick2_000120; Prestwick3_000120; TRIAMCINOLONE [MI]; TRIAMCINOLONE [INN]; TRIAMCINOLONE [JAN]; SCHEMBL4447; CHEMBL1451; Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11-beta,16-alpha)-; TRIAMCINOLONE [HSDB]; Lopac0_001179; BSPBio_000140; TRIAMCINOLONE [VANDF]; 4-08-00-03629 (Beilstein Handbook Reference); cid_31307; MLS002695935; TRIAMCINOLONE [MART.]; SPBio_002079; TRIAMCINOLONE [USP-RS]; TRIAMCINOLONE [WHO-DD]; BPBio1_000154; GTPL2870; orb1310282; orb3025007; BDBM41132; HY-B0328R; MSK2224; Triamcinolone (JP17/USP/INN); HMS1568G22; HMS2090D12; HMS2095G22; HMS2231E20; HMS3263L19; HMS3712G22; TRIAMCINOLONE [GREEN BOOK]; TRIAMCINOLONE [ORANGE BOOK]; EX-A4109; HY-B0328; Tox21_111332; Tox21_300178; Tox21_501179; TRIAMCINOLONE [EP MONOGRAPH]; EBC-11068; s1933; TRIAMCINOLONE [USP MONOGRAPH]; AKOS015895436; Tox21_111332_1; AC-2072; CCG-205253; DB00620; FT28383; LP01179; SDCCGSBI-0051146.P002; 11.beta.,16.alpha.,17.alpha., 21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione; SMP1_000300; NCGC00021580-03; NCGC00021580-04; NCGC00021580-05; NCGC00021580-06; NCGC00021580-07; NCGC00021580-08; NCGC00021580-16; NCGC00178404-03; NCGC00254049-01; NCGC00261864-01; (1S,2R,3aS,3bS,9aS,9bR,10S,11aS)-9b-fluoro-1,2,10-trihydroxy-1-(2-hydroxyacetyl)-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one; AS-13657; NCI60_000750; CS-0695010; EU-0101179; NS00007956; D00385; E70344; EN300-7400440; F787584; SR-01000000079; Q1074056; SR-01000000079-3; BRD-K77554836-001-03-3; BRD-K77554836-001-11-6; BRD-K77554836-001-14-0; TRIAMCINOLONE ACETONIDE IMPURITY A [EP IMPURITY]; Triamcinolone, European Pharmacopoeia (EP) Reference Standard; WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ GQ; Triamcinolone, United States Pharmacopeia (USP) Reference Standard; 1,4-Pregnadien-9alpha-fluoro-11beta,16alpha,17,21-tetrol-3,20-dione; 11|_,16|_,17|_,21-Tetrahydroxy-9|_-fluoro-1,4-pregnadiene-3,20-dione; 9.alpha.-Fluoro-11.beta.,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione; 9.alpha.-Fluoro-11.beta.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione; Pregna-1,20-dione, 9-fluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-; 11.beta.,17.alpha.,21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione; 9-FLUORO-11,BETA,,16.ALPHA.,17,21-TETRAHYDROXYPREGNA-1,4-DIENE-3,20-DIONE; 9.alpha.-Fluoro-11.beta.,17.alpha.,21-tetrahydroxypregna-1,4-diene-3,20-dione; Halcinonide Impurity 15; Triamcinolone; Triamcinolone Acetonide EP Impurity A; Pregna-1,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11.beta.,16.alpha.)-; Pregna-1,4-diene-3, 20-dione, 9-fluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-; 9.alpha.-Fluoro-11.beta.,16.alpha.,17.alpha., 21-tetrahydroxypregna-1,4-diene-3,20-dione; PREGNA-1,4-DIENE-3,20-DIONE, 9-FLUORO-11,16,17,21-TETRAHYDROXY-, (11.BETA.,16.ALPHA.); Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11beta,16alpha)-, tetrahydro deriv.Tên gọi khác